Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: A device-specific analysis of 7147 patients

Circulation

Volumn 104, Issue 6, 2001, Pages 642-647

  Stone, Gregg W ^a,b   Mehran, Roxana ^a   Dangas, George ^a   Lansky, Alexandra J ^a   Kornowski, Ran ^a   Leon, Martin B ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

Angioplasty; Complications; Stents

Indexed keywords

CREATINE KINASE MB;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART MUSCLE NECROSIS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0035822707     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3101.093902     Document Type: Article

References (22)

1. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: Insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT)
2. Effect of transient abrupt vessel: Closure during otherwise successful angioplasty for unstable angina on clinical outcome at six months
3. Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting
4. 3 blockade with percutaneous coronary intervention
5. Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: One-year outcome in the EPILOG trial
6. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions
7. Prognostic implication of creatine kinase elevation following elective coronary artery interventions
8. Results of the Balloon vs Optimal Atherectomy Trial (BOAT)
9. Creatine kinase release after successful percutaneous transluminal coronary angioplasty
10. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty
11. Myonecrosis after revascularization procedures
12. Primary stenting versus balloon angioplasty in occluded coronary arteries: The Total Occlusion Study of Canada (TOSCA)
13. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts
14. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality
15. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: An intravascular ultrasound study of 2256 patients
16. Incidence and consequences of periprocedural occlusion: The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry
17. Acute myocardial infarction
18. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
19. Platetet glycoprotein IIb/IIIa blockade with abciximab with low-dose heparin during percutaneous coronary revascularization
20. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade
21. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study
22. Randomised comparison of implantation of heparin-coated stems with balloon angioplasty in selected patients with coronary artery disease